FDA says it has approved the first seasonal flu vaccine made using cell culture system rather than egg based. This process shaves off four weeks in the production of the flu vaccine. Novartis produces Flucelvax.
MicrobeWorld App
Watch Live Events
Featured Image
Featured Video
FDA Approves Cell Culture-Based Seasonal Flu Vaccine
American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
Copyright © American Center for Microbiology 2012. All Rights Reserved.
